Seroprevalence and coinfections of Toxoplasma gondii in childbearing age women in Turkey

Iranian Journal of Public Health

Volumn 40, Issue 1, 2011, Pages 63-67

  Akyar, I ^a  

^a ACIBADEM UNIVERSITY   (Turkey)

Author keywords

Pregnant women; TORCH; Toxoplasma prevalence; Turkey

Indexed keywords

EID: 79955525320     PISSN: 22516085     EISSN: 22516093     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Jones JL, Kruszon-Moran D, Wilson M, McQuillan G, Navin T, McAuley JB (2001). Toxoplasma gondii infection in the United States: seroprevalence and risk factios. Am J Epidemiol, 154: 357-65.
2. Vimercati A, Greco P, D'Apolito A, Angelici MC, Possenti A, Carbonara S et al. (2000). Risk assessment of vertical transmission of Toxoplasma infections. Acta Biomed Ateneo Parmense, 71 (Suppl 1): 537-540.
3. Montoya JG, Liesenfeld O, Kinney S, Press C, and Remington JS (2001). VIDAS test for avidity of toxoplasma-specific im-munoglobulin G for confirmatory testing of pregnant women. J Infect Dis, 183(8): 1248-1253.
4. Ouermi D, Simpore J, Belem AM, Sanou DS, Karou DS, Ilboudo D, Bisseye C, Onadja SM, Pietra VPignatelli S, Gnoula C, Nikiema JB, Kabre GB (2009). Coinfection of Toxoplasma gondii with HBV in HIV-infected and uninfected pregnant women in Burkina Faso. Pak J Biol Sci, 12(17): 188-193.
5. Abu-Madi MA, Behnke JM, Dabritz HA (2010). Toxoplasma gondii seropositivity and co-infection with TORCH pathogens in high-risk patients from Qatar. Am J Trop Med Hyg, 82(4): 626-633.
6. Remington JS, McLeod R, Thulliez P and Desmonts G (2001). Toxoplasmosis. In: Infectious diseases of the fetus and the newborn infant. Eds, J.S. Remington and J Klein. 5th ed, W.B. Saunders, Philedelphia, pp.205-346.
7. Liesenfeld O, Montoya JG, Tathineni NJ, Davis M, Brown BW, Cobb Jr KL, Par- sonnet J, Remington JS (2001). Confirmatory serologic testing for acute toxoplasmosis and rate of induced abortions among women reported to have positive Toxoplasma immunoglobulin M antibody titers. Am J Obstet Gynecol, 184: 140-5.
8. Sibley D, Khan A, Ajioka W, Rosenthal BM (2009). Genetic diversity of Toxoplasmagondii in animals and humans. Philos Trans R Soc Lond B Biol Sci, 364(1530): 2749-61.
9. Diaz-Suarez O, Estevez J (2009). Seroepidemiology of toxoplasmosis in women of childbearing age from a marginal community of Maracaibo, Venezuela. Rev Inst Trop Sao Paulo, 51(1): 13-7.
10. Bouhamdan SF, Bitar LK, Saghir HJ, Bayan A, Araj GF (2010). Seroprevalence of Toxoplasma antibodies among individuals tested at hospitals and private laboratories in Beirut. J Med Liban, 58(1): 8-11.
11. Khurana S, Bagga R, Aggarwal A, Lyngdoh V, Shivapriya, Diddi K, Malla N (2010). Serological screening for antenatal toxoplasma infection in India. Indian J Med Microbiol, 28(2): 143-146.
12. Abdi J, Shojaee S, Mirzaee A, Keshavarz H. (2008). Seroprevalence of toxoplasmosis in pregnant women in Ilam Province, Iran. Iranian J Parasitol, 3(2): 34-7.
13. Harma M, Harma M, Gungen N, Demir N (2009). Toxoplasmosis in pregnant women in Sanliurfa, southeastern Anatolia city, Turkey. J Egypt Soc Parasitol. 2004; 34(2): 519-25.
14. Inci M, Yagmur G, Aksebzeci T, Kaya E, Yazar S (2009). The investigation of Toxo- plasma gondii seropositivity in women in the Kayseri province. Turkiye Parazitol Derg, 33(3): 191-194.
15. Public Health Service (1997). FDA public health advisory: limitations of Toxoplasma Ig M commercial test kits. Food and Drug Administration, Rockville, Md.
16. Liesenfeld O, Montoya JG, Kinney S, Pres C and Remington JS (2001). Effect of testing for Ig G avidity in the diagnosis of Toxoplasma gondii infection in pregnant women: experience in a US reference laboratory. J Infect Dis, 183:1248-53.